Pharmacology and Therapeutics

Latent Therapeutic Demand of Immunoglobulin therapies in neuropathies in the United States
Albert Farrugia, Megha Bansal

medRxiv 2020.05.27.20114579; doi: https://doi.org/10.1101/2020.05.27.20114579
Analysis of Crowdsourced Metformin Tablets from Individuals Reveals Widespread Contamination with N-Nitrosodimethylamine (NDMA) in the United States
Qian Wu, Evgenia Kvitko, Amber Jessop, Shannon Williams, Ryan C Costantino, Kaury Kucera, David Y Light

medRxiv 2020.05.22.20110635; doi: https://doi.org/10.1101/2020.05.22.20110635
Chloroquine, hydroxychloroquine, and COVID-19: systematic review and narrative synthesis of efficacy and safety
Micheal takla, Kamalan Jeevaratnam

medRxiv 2020.05.28.20115741; doi: https://doi.org/10.1101/2020.05.28.20115741
National Consumption of Antimalarial Drugs and COVID-19 Deaths Dynamics : an Ecological Study
Maxime Izoulet

medRxiv 2020.04.18.20063875; doi: https://doi.org/10.1101/2020.04.18.20063875
Pharmacokinetics of anti-tuberculosis drugs in multidrug resistant tuberculosis patients in India
Hemanth Kumar AK, Natarajan PL, Kannan T, SRIDHAR R, Kumar S, Vinod kumar V, Gomathi NS, Bharathiraja T, Sudha V, Balaji S, Ramesh Kumar S, Dina Nair, Tripathy SP, Geetha R

medRxiv 2020.05.26.20111534; doi: https://doi.org/10.1101/2020.05.26.20111534
Investigational treatments for COVID-19 may increase ventricular arrhythmia risk through drug interactions
Meera Varshneya, Itziar Irurzun-Arana, Chiara Campana, Rafael Dariolli, Amy Gutierrez, Taylor K Pullinger, Eric A Sobie

medRxiv 2020.05.21.20109397; doi: https://doi.org/10.1101/2020.05.21.20109397
Determinants of cardiac adverse events of chloroquine and hydroxychloroquine in 20 years of drug safety surveillance reports
Isaac V Cohen, Tigran Makunts, Talar Moumedjian, Masara Issa, Ruben Abagyan

medRxiv 2020.05.19.20107227; doi: https://doi.org/10.1101/2020.05.19.20107227
Investigation on the interaction between nifedipine and ritonavir containing antivirus regimens: a physiologically-based pharmacokinetic/pharmacodynamic analysis
Wan-jie Niu, Si-ze Li, Sha-sha Jin, Xi-ying Lin, Meng-wan Zhang, Wei-min Cai, Ming-kang Zhong, Xiao-qiang Xiang, Zheng Jiao

medRxiv 2020.05.19.20106658; doi: https://doi.org/10.1101/2020.05.19.20106658
Drug treatments affecting ACE2 in COVID-19 infection: a systematic review protocol
Hajira Dambha-Miller, Ali Albasri, Sam Hodgson, Chris Wilcox, Nazrul Islam, Shareen Khan, Paul Little, Simon J Griffin

medRxiv 2020.05.25.20100438; doi: https://doi.org/10.1101/2020.05.25.20100438
Plasma concentration and safety of lopinavir/ritonavir in patients with Covid-19: a retrospective cohort study
Laurent Chouchana, Sana Boujaafar, Ines Gana, Laure-Hélène Preta, Lucile Regard, Paul Legendre, Celia Azoulay, Etienne Canouï, Jeremie Zerbit, Nicolas Carlier, Benjamin Terrier, Solen Kernéis, Rui Batista, Jean-Marc Treluyer, Yi Zheng, Sihem Benaboud

medRxiv 2020.05.18.20105650; doi: https://doi.org/10.1101/2020.05.18.20105650

Pharmacology and Therapeutics

Pages